| Code | 32669 | ||||||||||
| MA number | EU/1/11/749/002 | ||||||||||
| Product Form: | tbl flm 30x300 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Sanofi B.V., Netherland | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 17.02.2012 |
| Validity: | 28.11.2027 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Caprelsa_Edukačné materiály pre pacientov a ošetrovateľov.pdf
|
| Dokument: |
Caprelsa_Edukačné materiály pre lekárov.pdf
|
| Dokument: |
Caprelsa_Karta pacienta.pdf
|
| Safety feature | Yes |
| Data update: | 02.12.2022 |
